Showing 1 - 2 results of 2 for search 'Ranjit. K. Sahoo', query time: 0.01s Refine Results
  1. 1
    Combined modality treatment with “dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide” chemotherapy and involved field radiotherapy for early stage natural Killer/T cell lymphoma with local tumor invasiveness: A single-institution study from India

    Combined modality treatment with “dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide” chemotherapy and involved field radiotherapy for early stage natural Kille... by Vineet G Gupta, Ajay Gogia, Lalit Kumar, Atul Sharma, Sameer Bakhshi, Mehar C Sharma, Saumyaranjan Mallick, Ahitagni Biswas, Prashant Mehta, Sanjay Thulkar, Ranjit K Sahoo, Rakesh Kumar

    Published 2018-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Olanzapine Versus NK1 Receptor Antagonist for Prevention of Carboplatin-Induced (AUC ≥4) Emesis: A Phase III, Double-Blind, Placebo-Controlled Randomized Trial From India

    Olanzapine Versus NK1 Receptor Antagonist for Prevention of Carboplatin-Induced (AUC ≥4) Emesis: A Phase III, Double-Blind, Placebo-Controlled Randomized Trial From India by Sneh Bhargave, Vinod Sharma, Babita Kataria, Atul Batra, Deepam Pushpam, Aparna Sharma, Raja Pramanik, Prabhat S. Malik, Ranjit. K. Sahoo, Sachin Khurana, Vishwajeet Singh, Sameer Bakhshi, Atul Sharma, Lalit Kumar, Akash Kumar

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: